FDA approves 1st treatment for rare neurological disease

The FDA has approved Zanvastro (zilganersen) injection to treat Alexander disease in pediatric and adult patients, making it the first FDA-approved treatment for the rare neurological disease. Zanvastro is also the first therapy to directly target the protein buildup that drives Alexander disease, according to a Sept. 3 news release. The disease affects fewer than […] The post FDA approves 1st treatment for rare neurological disease appeared first on Becker's Hospital Review | Healthc...